Nephros NEPH
NASDAQ NEPH
$3.71 +0.00 (+0.00%)
As of: Oct 1, 2026 · 3:59 PM EDT

Nephros (NEPH) Accumulated Expenses (2010 - 2026)

Updated

Nephros (NEPH) reported Accumulated Expenses of $965,000 for Q2 2026, up 25.2% from $771,000 a year earlier and up 45.8% from the prior quarter.

Analysis

Nephros (NEPH) Accumulated Expenses (2010 - 2026) Analysis & Trends

At the end of FY2025, Nephros posted Accumulated Expenses of $1.46 million, up 158.8% from FY2024.

  • Accumulated Expenses has a five-year compound annual growth rate of 33.8% (FY2020 to FY2025).
  • By year, Accumulated Expenses came in at $565,000 in FY2024 (-28.8%), $794,000 in FY2023 (+178.6%), $285,000 in FY2022 (-35.8%) and $444,000 in FY2021 (+30.2%).
  • Five-year quarterly Accumulated Expenses spans a low of $185,000 in Q2 2022 and a high of $1.46 million in Q4 2025.
  • Year over year, Accumulated Expenses has now increased in each of the last six quarters, with growth averaging 61.3% over the last eight quarters.
  • The high point for year-over-year Accumulated Expenses in five years was Q3 2025 (growth of 257.5%); the low point was Q2 2022 (a decline of 61.1%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $662,000 (Q1 2026), $1.46 million (Q4 2025) and $1.15 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn
10 Nephros 40.29 Mn 21.01 Mn 4.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 965,000.00
Mar 31, 2026 662,000.00
Dec 31, 2025 1.46 Mn
Sep 30, 2025 1.15 Mn
Jun 30, 2025 771,000.00
Mar 31, 2025 603,000.00
Dec 31, 2024 565,000.00
Sep 30, 2024 322,000.00
Jun 30, 2024 435,000.00
Mar 31, 2024 413,000.00
Dec 31, 2023 794,000.00
Sep 30, 2023 712,000.00
Jun 30, 2023 572,000.00
Mar 31, 2023 383,000.00
Dec 31, 2022 285,000.00
Sep 30, 2022 272,000.00
Jun 30, 2022 185,000.00
Mar 31, 2022 263,000.00
Dec 31, 2021 444,000.00
Sep 30, 2021 573,000.00
API Access

Nephros Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=NEPH&period=max&api_key=YOUR_API_KEY